CTSO
NASDAQ
US
Cytosorbents Corporation - Common Stock
$0.58
▲ +$0.04
(+6.58%)
Vol 253K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$40.1M
ROE
-91.5%
Margin
-30.8%
D/E
161.50
Beta
1.37
52W
$1–$2
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
75.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 40.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.05 | $-0.09 | $-0.04 |
| Sep 2025 | $-0.05 | $-0.05 | $0.00 |
| Jun 2025 | $-0.05 | $0.03 | +$0.08 |
| Mar 2025 | $-0.07 | $-0.02 | +$0.05 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $8.6M | $9.2M | $8.7M | $9.6M | $9.5M |
| Net Income | -$2.8M | -$7.9M | -$1.5M | $1.9M | -$3.2M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -77.6% | -77.6% | -77.6% | -77.6% | -91.5% | -91.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 20.2% | -28.5% | -28.5% | -28.5% | -30.8% | -30.8% |
| Gross Margin | 70.9% | 73.2% | 73.2% | 73.2% | 77.0% | 77.0% |
| D/E Ratio | 124.09 | 124.09 | 124.09 | 124.09 | 161.50 | 161.50 |
| Current Ratio | 2.34 | 2.34 | 2.34 | 2.34 | 2.11 | 2.11 |
Key Ratios
ROA (TTM)
-22.1%
P/S (TTM)
1.17
P/B
4.5
EPS (TTM)
$-0.19
CF/Share
$-0.50
Rev Growth 3Y
-6.2%
52W High
$1.61
52W Low
$0.60
$0.60
52-Week Range
$1.61
Financial Health
Free Cash Flow
-$2.5M
Net Debt
$19.6M
Cash
$7.5M
Total Debt
$27.1M
As of Sep 30, 2025
How does CTSO compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
CTSO valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
1.2
▼
55%
below
peers
(2.6)
vs Peers
vs Industry
Undervalued
P/B ratio
4.5
▲
62%
above
peers
(2.8)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
CTSO profitability vs Health Care peers
ROE
-91.5%
▼
138%
below
peers
(-38.5%)
vs Peers
vs Industry
Weak
Net margin
-30.8%
▼
25%
below
peers
(-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
77.0%
▲
46%
above
peers
(52.9%)
vs Peers
vs Industry
Top tier
ROA
-22.1%
▼
4%
below
peers
(-21.2%)
vs Peers
vs Industry
In line
CTSO financial health vs Health Care peers
D/E ratio
161.5
▲
738%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
2.1
▼
2%
below
peers
(2.2)
vs Peers
vs Industry
In line
Beta
1.4
▲
30%
above
peers
(1.1)
vs Peers
vs Industry
More volatile
CTSO fundamentals radar
CTSO
Peer median
Industry
CTSO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CTSO vs peers: key metrics
Top Holders
Top 5: 19.73%Avenir Corp
8.33%
$3.1M
Vanguard Group Inc
3.51%
$1.3M
Skylands Capital, LLC
2.95%
$1.1M
Neuberger Berman Group, LLC
2.59%
$964K
CM Management, LLC
2.35%
$876K
As of Dec 31, 2025
Latest News
No related news yet